Abstract
Aim:
To generate a monoclonal antibody (McAb) against cell surface F1F0 ATP synthase (ATPase) and observe its antitumoral activity on both human umbilical vein endothelial cells (HUVEC) and tumor cells.
Methods:
Hybridoma cells secreting McAb against ATPase were produced by polyethylene glycol-mediated fusions and screened by ELISA. The specificity of McAb was demonstrated by immunofluorescence and confocal imaging, as well as flow cytometry analysis. After the blockade of surface ATPase with McAb on HUVEC and human breast adenocarcinoma MDA-MB-231 cells, an AT P determination kit and CellTiter96 AQueous Assay (MTS) assay were used to detect the effect of the antibody on extracellular ATP modification and cell proliferation. A cellular cytotoxicity assay in combination with doxorubicin, and a cell migration assay on MDA-MB-231 cells were used to determine the antitumoral activity. Finally, a HUVEC tube formation assay was used to detect the antiangiogenic effect of McAb178-5G10.
Results:
A monoclonal antibody (McAb178-5G10) against the β-subunit of ATPase was generated, and its reactivity toward HUVEC and tumor cells was studied. We demonstrate that McAb178-5G10 binds to ATPase at the cell surface, where it is able to inhibit AT P synthesis. This antibody also prevents the proliferation of HUVEC and MDA-MB-231 cells. Furthermore, McAb178-5G10 enhances the tumoricidal effects of doxorubicin (P<0.05), inhibits the migration of MDA-MB-231 in transwell assays (P<0.01), and disrupts HUVEC tube formation on Matrigel (P<0.01).
Conclusion:
McAb178-5G10 binds preferentially to cell surface ATPase, blocks ATP synthesis, and exhibits both antiangiogenic and antitumorigenic effects.
Similar content being viewed by others
Article PDF
References
Cross RL . Molecular motors: turning the ATP motor. Nature 2004; 427: 407–8.
Chi SL, Pizzo SV . Cell surface F0F1 ATP synthase: a new paradigm? Ann Med 2006; 38: 429–38.
Moser TL, Kenan DJ, Ashley TA, Roy JA, Goodman MD, Misra UK, et al. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci USA 2001; 98: 6656–61.
Moser TL, Stack MS, Asplin I, Enghild JJ, Højrup P, Everitt L, et al. Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc Natl Acad Sci USA 1999; 96: 2811–6.
Chi SL, Wahl ML, Mowery YM, Shan S, Mukhopadhyay S, Hilderbrand SC, et al. Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase. Cancer Res 2007; 67: 4716–24.
Chi SL, Pizzo SV . Angiostatin is directly cytotoxic to tumor cells at low extracellular pH: a mechanism dependent on cell surface-associated ATP synthase. Cancer Res 2006; 66: 875–82.
Zhao Y, Zhang W, Kho Y, Zhao Y . Proteomic analysis of integral plasma membrane proteins. Anal Chem 2004; 76: 1817–23.
Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J, Xue Q . Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin Oncol 2003; 129: 43–51.
Peng Y, Zhang X, Wang K, Jiang P, Jiao BH, Ni J . Proteome analysis of hepatocellular carcinoma cell lines with different metastasis potentials by two-dimensional liquid chromatography. World J Digestol 2007; 15: 1482–7.
Aggeler R, Coons J, Taylor SW, Ghosh SS, Garcia JJ, Capaldi RA, et al. A functionally active human F1F0 ATPase can be purified by immunocapture from heart tissue and fibroblast cell lines, Subunit structure and activity studies. J Biol Chem 2002; 277: 33 906–12.
Sakaguchi N, Kimura T, Matsushita S, Fujimura S, Shibata J, Araki M, et al. Generation of high-affinity antibody against T cell-dependent antigen in the Ganp gene-transgenic mouse. J. Immunol 2005; 174: 4485–94.
Köhler G, Milstein C . Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–7.
Bueno C, Rodriguez-Caballero A, García-Montero A, Pandiella A, Almeida J, Orfao A . A new method for detecting TNF-alpha-secreting cells using direct-immunofluorescence surface membrane stainings. J Immunol Methods 2002; 264: 77–87.
Zucker RM, Jeffay SC . Confocal laser scanning microscopy of whole mouse ovaries: excellent morphology, apoptosis detection, and spectroscopy. Cytometry A 2006; 69: 930–9.
Burwick NR, Wahl ML, Fang J, Zhong Z, Moser TL, Li B, et al. An inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface. J Biol Chem 2005; 280: 1740–5.
Lukong KE, Richard S . Breast tumor kinase BRK requires kinesin-2 subunit KAP3A in modulation of cell migration. Cell Signal 2008; 20: 432–42.
Guo K, Li J, Wang H, Osato M, Tang JP, Quah SY, et al. PRL-3 initiates tumor angiogenesis by recruiting endothelial cells in vitro and in vivo. Cancer Res 2006; 66: 9625–35.
Kirley TL . Complementary DNA cloning and sequencing of the chicken muscle ecto-ATPase: Homology with the lymphoid cell activation antigen CD39. J Biol Chem 1997; 272: 1076–81.
Scotet E, Martinez LO, Grant E, Barbaras R, Jeno P, Guiraud M, et al. Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity 2005; 22: 71–80.
Cloos PA, Christgau S . Post-translational modifications of proteins: implications for aging, antigen recognition, and autoimmunity. 2004; 5: 139–58.
Martinez LO, Jacquet S, Esteve JP, Rolland C, Cabezón E, Champagne E, et al. Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis. Nature 2003; 421: 75–9.
Das B, Mondragon MO, Sadeghian M, Hatcher VB, Norin AJ . A novel ligand in lymphocyte-mediated cytotoxic: expression of the beta-subunit of H+ transporting ATP synthase on the surface of tumor cell lines. J Exp Med 1994; 180: 273–81.
O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994; 79: 315–28.
Kenanl DJ, Wahl ML . Ectopic localization of mitochondrial ATP synthase: a target for anti-angiogenesis intervention? J Bioenerg Biomembr 2005; 37: 461–5.
Author information
Authors and Affiliations
Corresponding authors
Additional information
This work was supported by the National High Technology Research and Development Program of China (863 Program, No 2007AA02Z180).
Rights and permissions
About this article
Cite this article
Zhang, X., Gao, F., Yu, Ll. et al. Dual functions of a monoclonal antibody against cell surface F1F0 ATP synthase on both HUVEC and tumor cells. Acta Pharmacol Sin 29, 942–950 (2008). https://doi.org/10.1111/j.1745-7254.2008.00830.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2008.00830.x
Keywords
This article is cited by
-
DJ-1 interacts with the ectopic ATP-synthase in endothelial cells during acute ischemia and reperfusion
Scientific Reports (2022)
-
The function of Cav-1 in MDA-MB-231 breast cancer cell migration and invasion induced by ectopic ATP5B
Medical Oncology (2021)
-
Tumor-secreted anterior gradient-2 binds to VEGF and FGF2 and enhances their activities by promoting their homodimerization
Oncogene (2017)
-
A humanized chimeric antibody Hai178 targeted to the β subunit of F1F0 ATP synthase
Tumor Biology (2016)
-
Combination therapy targeting ectopic ATP synthase and 26S proteasome induces ER stress in breast cancer cells
Cell Death & Disease (2014)